EUVIMEDEUVIMED entdecken
Crossref

Identification of 3,5-Bis (2-Ethoxybenzylidene) Piperidin-4-one as a Monocarbonyl Curcumin Analog Inhibiting Cell-Intrinsic NF-κB Activity in 4T1 Breast Cancer Cells

Sana Jabbar, Sisca Ucche, Farooq Muhammad Irshad, Suthasinee Seephan, So-Ichiro Sasaki, Retno Murwanti, Ritmaleni, Yoshihiro Hayakawa

Biological and Pharmaceutical Bulletin · 17.04.2026 · 49 (4) · 725-731

DOI: 10.1248/bpb.b25-00785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, erschienen am 17.04.2026. Verfasst von Sana Jabbar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Host Defences, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan. Hauptthemen laut MEDLINE: Curcumin, NF-kappa B, Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although numerous biological properties of curcumin, a bioactive polyphenol from the rhizome of turmeric (Curcuma longa), have been documented, its poor bioavailability limits clinical application. Therefore, identifying new analogs with improved pharmacokinetics and pharmacological properties is essential. Given that curcumin and its related compounds are known to inhibit cancer cell progression and metastasis through nuclear factor-kappaB (NF-κB) signaling inhibition, we investigated 58 newly synthesized, structurally diverse monocarbonyl curcumin analogs. Their inhibitory effects on intrinsic NF-κB activity were assessed in breast cancer cells using the 4T1 cell line expressing a luciferase NF-κB reporter. Among the 58 monocarbonyl curcumin analogs, 3,5-bis(2-ethoxybenzylidene)piperidin-4-one (E145) exhibited potent inhibition of NF-κB activity in 4T1 breast cancer cells. Based on the structure-activity relationship analysis, the central heterocyclic monocarbonyl linker structure of E145 contributed to its increased potency in NF-κB inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminNF-kappa BBreast NeoplasmsAntineoplastic AgentsPiperidinesAnimalsFemaleCell Line, TumorStructure-Activity RelationshipMiceHumans

Stichwörter der Autor:innen

anticancerbreast cancercurcumin analognuclear factor-kappaB

Substanzen

CurcuminNF-kappa BAntineoplastic AgentsPiperidines

Autor:innen und Institutionen

  • Section of Host Defences, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan.
  • Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.
  • Curcumin Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.

Zitieren

APA

Jabbar, S., Ucche, S., Irshad, F. M., Seephan, S., Sasaki, S. I., Murwanti, R., Ritmaleni, & Hayakawa, Y. (2026). Identification of 3,5-Bis (2-Ethoxybenzylidene) Piperidin-4-one as a Monocarbonyl Curcumin Analog Inhibiting Cell-Intrinsic NF-κB Activity in 4T1 Breast Cancer Cells. Biological and Pharmaceutical Bulletin, 49(4), 725-731. https://doi.org/10.1248/bpb.b25-00785

Vancouver

Jabbar S, Ucche S, Irshad FM, Seephan S, Sasaki SI, Murwanti R, et al. Identification of 3,5-Bis (2-Ethoxybenzylidene) Piperidin-4-one as a Monocarbonyl Curcumin Analog Inhibiting Cell-Intrinsic NF-κB Activity in 4T1 Breast Cancer Cells. Biological and Pharmaceutical Bulletin. 2026;49(4):725-731. doi:10.1248/bpb.b25-00785

BibTeX
@article{Jabbar2026,
  author = {Jabbar, Sana and Ucche, Sisca and Irshad, Farooq Muhammad and Seephan, Suthasinee and Sasaki, So-Ichiro and Murwanti, Retno and Ritmaleni and Hayakawa, Yoshihiro},
  title = {Identification of 3,5-Bis (2-Ethoxybenzylidene) Piperidin-4-one as a Monocarbonyl Curcumin Analog Inhibiting Cell-Intrinsic NF-κB Activity in 4T1 Breast Cancer Cells},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2026},
  volume = {49},
  number = {4},
  pages = {725--731},
  doi = {10.1248/bpb.b25-00785}
}
Kostenlos starten →